Fundraising Fox

Jecure Therapeutics

San Diego, US · Founded 2015 · Delaware corporation · 2 employees on LinkedIn

Founders & leadership

JS
Jeffrey Stafford, Ph.D.Executive
JV
James Veal, Ph.D.Executive
AF
Ariel Feldstein, M.D.Named on SEC filing

Board

BB
Bradley Bolzon, Ph.D.Board director
TW
Thomas Woiwode, Ph.D.Board director

Reported raises · per SEC filings

Form D private placements

$18M disclosed across 2 rounds · 2017–2018

$3MraisedJul 2018 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey Stafford, Ph.D.Executive Officer, Director
  • Thomas Woiwode, Ph.D.Director
  • Bradley Bolzon, Ph.D.Director
  • Ariel Feldstein, M.D.Director
  • James Veal, Ph.D.Executive Officer
Offering amount
$3M
Amount sold
$3M
First sale
Jul 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$15MraisedDec 2017 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bradley Bolzon, Ph.D.Director
  • Ariel Feldstein, M.D.Director
  • Jeffrey Stafford, Ph.D.Executive Officer, Director
  • James Veal, Ph.D.Executive Officer
  • Thomas Woiwode, Ph.D.Director
Offering amount
$15M
Amount sold
$15M
First sale
Feb 2017
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Jecure Therapeutics raised?
Jecure Therapeutics has disclosed $18M raised across 2 rounds.
Where is Jecure Therapeutics headquartered?
Jecure Therapeutics is headquartered in San Diego, US.